These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 117256)

  • 1. A case of pseudovitamin D deficiency-like rickets in an infant treated with 1,25-dihydroxycholecalciferol. Preliminary note.
    Vecchio F; Carnevale F; Paganetti G; di Bitonto G; Marinelli G
    J Inherit Metab Dis; 1978; 1(4):183-5. PubMed ID: 117256
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to vitamin D and parathyroid hormone.
    Moses AM
    N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H; Bordier P
    Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
    [No Abstract]   [Full Text] [Related]  

  • 4. Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.
    Chesney RW; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1981 Jan; 135(1):34-7. PubMed ID: 6969986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid-hormone concentrations in nutritional rickets.
    Joffe BI; Hackeng WH; Seftel HC; Hartdegen RG
    Clin Sci; 1972 Jan; 42(1):113-6. PubMed ID: 5008532
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D and vitamin D dependency.
    Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
    Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
    Chesney RW; Hamstra A; Jax DK; Mazess RB; DeLuca HF
    Contrib Nephrol; 1980; 18():55-71. PubMed ID: 7353380
    [No Abstract]   [Full Text] [Related]  

  • 8. Cystinotic rickets treated with vitamin D metabolites.
    Etches P; Pickering D; Smith R
    Arch Dis Child; 1977 Aug; 52(8):661-4. PubMed ID: 921315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW; Brickman AS
    Adv Exp Med Biol; 1978; 103():473-86. PubMed ID: 362852
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal malabsorption presenting as congenital rickets.
    Begum R; Coutinho ML; Dormandy TL; Yudkin S
    Lancet; 1968 May; 1(7551):1048-52. PubMed ID: 4171742
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 13. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory findings in a child with pseudo-vitamin D deficiency rickets.
    Matsuda I; Sugai M; Ohsawa T
    Helv Paediatr Acta; 1969 Jun; 24(3):329-36. PubMed ID: 5800164
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypophosphatemic rickets: effect of 1 alpha, 25-dihydroxyvitamin D3 on growth and mineral metabolism.
    Chan JC; Bartter FC
    Pediatrics; 1979 Oct; 64(4):488-95. PubMed ID: 492815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and therapeutic effects of 1 alpha-hydroxycholecalciferol in different types of Fanconi syndrome.
    Kitagawa T; Akatsuka A; Owada M; Mano T
    Contrib Nephrol; 1980; 22():107-19. PubMed ID: 6893175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infants.
    Senterre J; David L; Salle B
    Ann Endocrinol (Paris); 1979; 40(2):163-4. PubMed ID: 475308
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
    Massry SG; Goldstein DA; Malluche HH
    Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of the rickets of cystinosis with 1-alpha-hydroxycholecalciferol.
    Gertner JM; Brenton DP; Dent CE; Domenech M
    Calcif Tissue Res; 1977 May; 22 Suppl():63-7. PubMed ID: 912591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.